17 Congress Of The European Society For Organ .
17th Congress of the European Society for Organ TransplantationFROM THE HEART F EUROPE TTHE WORLD F TRANSPLANTATION13-16 September 2015 Brussels, BelgiumSAVETHEDATE!Preliminary Program
The biennial congress of ESOT will take place in thecapital of Europe – the theme for the meeting is‘From the Heart of Europe to the World ofTransplantation’. ESOT 2015 will build on the recentvery successful meetings in Vienna and Glasgowwith all forms of modern educational and trainingaids in use. Besides different State of the Art sessionsdealing with several, still burning questions about organ donation and transplantation, manyimportant European contributions in the field of organ and tissue transplantation as well asprocurement will be highlighted. Attention will also be given to the European view in relation toethical and legal aspects in the field of donation and transplantation.This is Brussels callingBrussels is the thriving centre of Europe.Brussels is home to the European Commission, Parliament and NATO, a buzzing, influential citywhere history is made. The city is a key European commercial hub too, a base for manyprogressive international companies. But more than that, Brussels is a compact city, friendly,positive, cosmopolitan, easy to get around. For a major European capital, Brussels issurprisingly eco-friendly too, peppered with parks and green spaces. A walk through Brusselstakes you through a potted architectural history, from ancient medieval buildings to strikinglymodern edifices, taking in the Art Nouveau styling of illustrious architect Victor Horta alongthe way.We look forward to seeing you at a very fruitful and memorablecongress in the capital of the European Union!Jan Lerut and Dirk Van Raemdonck,Congress ChairsWhat we are planningThe Scientific Program Committee is made up of a blend of ESOT leaders, internationallyestablished experts and young and talented transplant physicians, surgeons and scientists,all active in the various fields of transplantation. What are we planning for Brussels 2015?We want to set up a congress that reflects the “global” dimension that transplantation hasacquired over the years. Indeed, today transplantation ranges from cells, to isolated organs,multi-organs and even composite tissue allograft transplantation. It is performed on allcontinents, requires the collaboration of a high number of distinct specialist areas, and is stillthe focus of burgeoning clinical and basic research. But there is more to it than that!We are facing exciting times where the idea of organ transplantation is being expanded to abroader concept of functional organ replacement, in which new technologies are likely to playa prominent role in the very near future. Realization of ideas such as organ regeneration, bioengineering or 3D-printing may be around the corner. The ambition of this Congress is topresent the highlights of transplantation today and what we think they might be tomorrow!We will strive to capture this diversity in the development of the scientific program so that,whether young or old, scientist, surgeon or physician, whether looking for up-to-dateknowledge on daily clinical practice or cutting edge research, every attendee can be sure tofind a relevant and stimulating session.We welcome your contributions and to sharing latest researches and clinical cases.Daniel Abramowicz and Thierry BerneySPC Chairs
Top 10 Reasons to Attend:1.Enjoy a stimulating rejuvenated format with a focus on interaction and informationexchange AND the latest developments in the field of transplantation.2. Be inspired, educated, connected and entertained.3. Moving "Beyond the Horizon" – with experts and innovative thinkers from all fields.4. Understand the latest trends in biomarkers, biologicals and immunosuppression andhow this may change patient care.5. Learn about the latest discoveries in the science of transplantation and aging.6. Experience translational research and recent developments at the interjunctionbetween basic science and clinical care.7.Attend courses addressing the greatest surgical or immunological challenges.8.Discuss present and upcoming challenges in transplantation: where business,legislation and medicine/science meet.9.Present your work and be selected as a case/topic for focused discussions –guided and instructed by key opinion leaders in the field.10. Get engaged in this interactive meeting and take an active role in shaping thefuture of transplantation research and medicine.Table of content2 Scientific Program Overview18 Registration fees4 Committees19 Submit an abstract5 Speciality update Symposia20 ESOT 2015 Congress Awards12 Preliminary Program24 Information17th Congress of the European Society for Organ Transplantation
Scientific Program OverviewSunday, September 13Monday, September 1408.00 09.00 h13.00 14.30 h14.45 16.15 hOrgan Donation Meeting by EDTCOCorporate Parallel SymposiaEducation Committee Campfire09.10 10.40 hState of the Art 3Global warmingin transplantationB-yond the horizon:humoral responsesin transplantationDecision tree orlottery: allocatinggrafts and therapiesCoffee break11.10 12.40 hFull Oral SessionsBest AbstractChallengeThe Devil’sAdvocate13.00 14.00 hCorporate ParallelSymposiaFuture LeadersForum by YPTBrief OralSessionsOf men and machineCorporate Plenary Symposium15.35 16.00 h'Author Speed dating'OpeningNetworking Event19.00 22.00 hState of the Art 2Plenary Session 2ESOT meets the WorldBrief OralSessionsBrief Oral SessionsState of the Art 110.40 11.10 hA Night at the SquareCoffee break16.00 17.00 hBeyond theHorizonThe future ofhuman bodyBeyond theHorizonThe race oftolerance withregenerativemedicine17.00 18.00 hHOTT ProjectWorkshopESOT meets theEditors18.00 19.30 h19.00 20.00 hFull Oral Sessions14.05 15.35 hOpening & Plenary Session 116.30 19.00 hHealthcare Allied ProfessionalWorkshop by ETAHPEthical, Legal andPsychosocial by ELPATVascularized Composite by VCABasic Science by BSCThoracic by ECTTAEKITA&ERA-EDTA DESCARTESJoint Symposium09.00 12.50 hPancreas & Islets by EPITALiver & Intestine by ELITASPECIALTY SYMPOSIAFull OralSessionsCorporate PlenarySymposiumBrief OralSessions
Tuesday, September 1508.00 09.00 h09.10 10.40 hFull Oral SessionsState of the Art 4The new frontier:transplantationacross antibodybarriersBrief Oral SessionsState of the Art 5The enemy within:improvingcompliance anddrug levels10.40 11.10 hCoffee break11.10 12.40 hGuess what?Striking clinicalcasesWednesday, September 1608.00 09.00 hState of the Art 6Markers & makersof success andfailure09.10 10.40 h10.40 11.10 hBrief Oral SessionsLate BreakingSessionState of the Art 7State of the Art 8State of the Art 9Immunosuppression:Is the pipelineempty?Cell therapy:Hit or miss?Life aftertransplantation:blessing or curse?Full Oral SessionsCoffee breakBeyond the HorizonFull Oral SessionsThe Devil’sAdvocate11.10 13.00 hPresidential Session &Honorary Membership CeremonyCLOSING13.00 14.00 hRising StarsVideo Sessionby YPTCorporate ParallelSymposiaBrief OralSessionsWho should attend?Plenary Session 314.05 15.35 hTransplantation 2.0.1515.35 16.00 h16.00 17.00 h17.00 18.30 hThe target audience for this conferenceincludes all fields involved in healthcare and research with an affiliation intransplantation. This includes but is notlimited to:Coffee breakBeyond the HorizonCrazy transplants ortransplants oftomorrow?Beyond the HorizonOrgan resuscitationlabBrief OralSessionsCorporate PlenarySymposiumFull Oral SessionsTransplant surgeonsPhysicians of all fields with aninvolvement in transplantationCoordinators, Nurses18.30 19.30 hESOT GENERALASSEMBLYBrief OralSessions'Author SpeedDating' CocktailGeneral surgeons and clinicianswith an interest in transplantationTransplant scientistsNutrition and rehabilitationspecialists and coordinatorsTransplant pharmacistsFurther, health care professionals withan involvement in treatment of organfailure, cell therapy, tissue andregenerative medicine are warmlywelcome to our conference.
ESOT 2015 Brussels Congress Local Organizing CommitteeChairs:Jan LerutDirk Van RaemdonckMembers:Olivier Detry, Liège (ULG)Vincent Donckier, Brussels (ULB)Patrick Evrard, Mont-Godinne (UCL)Jacques Pirenne, Leuven (KUL)Xavier Rogiers, Ghent (UG)Bernard Stockman, Aalst (OLV)Martin Wissing, Brussels (VUB)Dirk Ysebaert, Antwerp (UA)ESOT 2015 Scientific Program CommitteeChairs:Daniel Abramowicz, Antwerp, BelgiumThierry Berney, Geneva, SwitzerlandMembers:Patrizia Burra, Padua, Italy Franco Citterio, Rome, Italy Edward Geissler, Munich, Germany Denis Glotz, Paris, France Maarten Naesens, Leuven, Belgium Gabriel Oniscu, Edinburgh,United Kingdom Andreas Pascher, Berlin, Germany Luciano Potena, Bologna, Italy AxelRahmel, Leiden, The Netherlands Olivier Thaunat, Lyon, France Teun van Gelder, Rotterdam,The Netherlands Thomas Wekerle, Vienna, AustriaESOT 2015Organizing ExecutiveESOT 2015 SponsorshipAdvisory CommitteeThierry BerneyJan LerutMaarten NaesensGabriel OniscuOlivier ThaunatThierry Berney, Geneva, SwitzerlandJohn Forsythe, Edinburgh, United KingdomStefan Schneeberger, Innsbruck, AustriaAnnalisa Ponchia, ESOT Executive OfficerESOT 2014 – 2015 CouncilPresident: John Forsythe, Edinburgh, United KingdomPast President: Carla Baan, Rotterdam, The NetherlandsSecretary: Thierry Berney, Geneva, SwitzerlandTreasurer: Stefan Schneeberger, Innsbruck, AustriaCouncillors:Marina Berenguer, Valencia, Spain Diego Cantarovich, Nantes, France Franco Citterio, Rome,Italy Aksel Foss, Oslo, Norway Robert Langer, Budapest, Hungary Ugo Livi, Udine, Italy BirgitSawitzki, Berlin, Germany Jonas Wadström, Stockholm, Sweden Dirk Ysebaert, Antwerp, BelgiumMembers:Lionel Badet, Lyon, France – VCA Committee Chair D.L. Bensdorp – The Netherlands Lisa Burnapp,Bristol, United Kingdom – EDTCO Chair Undine Gerlach, Berlin, Germany – YPT Committee Chair Sir Peter Morris, London, United Kingdom – CET Director Paolo Muiesan, Brimingham, UnitedKingdom – ELITA Chair Rainer Oberbauer, Vienna, Austria – EKITA Chair Vassilios Papalois, London,United Kingdom – Education Committee Chair Rutger Ploeg, Oxford, United Kingdom – AmbassadorCommittee Chair Luciano Potena, Bologna, Italy – ECTTA Chair Johann Pratschke, Innsbruck,Austria – EPITA Chair Willem Weimar, Rotterdam, The Netherlands – ELPAT Chair Thomas Wekerle,Vienna, Austria – Basic Science Committee ChairExecutive Officer: Annalisa Ponchia, Padua, Italy
SPECIALTY UPDATE SYMPOSIASunday, September 13, 201508.45 – 12.50 Specialty Update Symposium:Advances and challenges of Liver Transplantation for HCV liver cirrhosis08.45 – 09.00 IntroductionSession 1: Liver Transplantation for patients with HCV Liver CirrhosisLiver transplantation for HCV liver cirrhosis in Europe – results from the ELTRThe new weapons and their combinations: the present and 5 year outlookExpected epidemiologic changes in the liver transplant lists in EuropeThe availability of new DAAs through EuropeSession 2: The new treatments for Hepatitis C in liver transplantcandidates and recipientsNew regimens in listed patients and ELITA recommendationsNew regimens for post transplant HCV disease recurrence andELITA recommendationsCost effectiveness and sustainability of the new regimensThe point of view of the patientELITA in pills: The European Liver and Intestine Transplantation Association is a multidisciplinary Society of health professionals in liver and intestine transplantation which is theofficial professional society delegated by ESOT for liver and intestine transplantation inEurope.Goals: To provide a range of educational activities, stimulate discussion and influenceEuropean legislation in liver and intestine transplantation. In partnership with the EuropeanLiver Transplant Registry to stimulate clinical research and publications from analysis of theregistry.Aim: Our aim is to set guidelines and standards and to provide education and support in liverand intestine transplantation within the European Countries.Objectives: To provide the liver transplant professionals with up to date information ondonor selection, anatomical and surgical technical pitfalls and management of recipientsafter small for size syndrome in split and living donor liver transplants.Target audience: Liver transplant surgeons and hepatologists, HPB surgeons andgeneral hepatologists, HPB oncologists, specialist nurses in liver transplantation, HPB,hepatology and oncology.ing challenges in organ quality.medical student with an interest in transplantation of pancreas and islets.17th Congress of the European Society for Organ Transplantation
SPECIALTY UPDATE SYMPOSIASunday, September 13, 201509.00 – 12.50 Specialty Update Symposium:Future Challenges in Pancreas and Islet TransplantationSession 1: The future of therapy of diabetesIs pancreas tx still justified?Is islet tx justified?We do not need either – we have insulin and technologySession 2: Scaffolding and encapsulation – The futureThe first clinical experience with scaffolding in InsulintherapyStem cells are the futureEncapsulationEPITA in pills: The European pancreas and Islet Transplantation Association is a section of ESOTfounded to provide a Forum for the pancreas and islet transplantation community in Europe.Goals: To facilitate the exchange of information of the field of pancreas and islet transplantation.Aim: The aim of EPITA is to contribute to the development of the pancreas and islettransplantation field and of alternate forms of beta-cell replacement therapy for the benefit ofpatients suffering from type 1 diabetes.Objectives: To review recent developments in pancreas and islet transplantation.To aim for an excellent graft survival despite increasing challenges in organ quality.Target audience: Transplant surgeons and physicians, transplant coordinator, nurses andmedical student with an interest in transplantation of pancreas and islets.ESOT 2013, Vienna
SPECIALTY UPDATE SYMPOSIASunday, September 13, 201509:00 – 12:50 EKITA-DESCARTES Joint Symposium:Personalization in TransplantationDefinition of sensitization (including solid phase technologies) – stratification and impact onthe success of the TransplantImpact of sensitization on the waiting time – Simulations of real world dataCost-effectiveness of ABO-incompatible kidney transplantation and kidney paired donationDiagnosis and Treatment of ABMR based on the individual immunologic profileNovel tools/biomarkers to stratify diagnosis, prognosis and prediction using omicstechnologiesiTransplant: bioinformatics tools to predict successQ&A to personalization in transplantation – live pollsEKITA in pills: EKITA is the kidney section of ESOT and deals with all aspects of renaltransplantation. As a European platform, EKITA supports research, education and clinical workin this area. Furthermore, EKITA is highly ambitious in preparing policies and creatingtransnational interactions to advance renal allografting in all European member states.Goals: The main goal of EKITA is to improve quality of life of people with ESRD by advancing allaspects of kidney transplantation.Aims: The ultimate aim of EKITA is the optimization of renal transplantation trough activities inresearch, education, clinical collaboration and health policy.Objectives: To provide an overview and offer specific solutions for the 'complicated'/sensitized patient. Solutions range from individualization through omics technologies tobioinformatics approaches.Target audience: Transplant surgeons and physicians, nephrologist, immunologists at allstages of training and expertise.ESOT 2013, Vienna17th Congress of the European Society for Organ Transplantation
SPECIALTY UPDATE SYMPOSIASunday, September 13, 201509:00 – 12:50 Specialty Update Symposium:Prevention, diagnosis and treatment of early and late thoracic graftdysfunction: a journey with the graft from the donor to the long-termrecipientSession1: Thoracic organ donor management: setting the standards and pushing the limitsReport from the consensus conference on thoracic organ donors: recommendations and unmetDebate: How to improve transportation and reconditioning of lungs:- reconditioning while warm perfusion- cold transportation and then bench reconditioningHow to optimize heart preservation and recoveryResuscitating and transplanting a non-beating heart: “it-could-work!”Session 2: Controversy and new knowledge in the management of machines and immunityDebate: Optimize transplantation timing in VAD patients on the waiting list:- Only stable VAD patients should be transplanted- Only complicated VAD patients should be transplantedModalities, indications and outcomes of patients needing ECMO support before lungtransplantationClinical manifestations and diagnosis of lung AMRMechanisms of antibody mediated injury: looking for therapeutic targestsECTTA in pills: The Thoracic Committee has been endorsed to promote initiatives aimed atimproving the educational and scientific opportunities ESOT can offer to professionalsinvolved in heart and lung transplantation.Goals: Our ambition is to become a gathering home to foster scientific growth, exchangeprograms, collaborative projects and funding opportunities dedicated to European heart andlung transplantation programs.Aim: Improve quality of care for patients with end-stage heart or lung disease and for thoracicorgan transplant recipients. Advance education and stimulate networking amongst thoracictransplant professionals.Objectives: To provide updates on the etiologies, mechanisms, treatment strategies anddiagnostic tools of early and late dysfunction of the transplanted heart and lungs. Thelectures will focus on the main strategies and mechanisms leading to graft dysfunctionstarting from donor and organ management, to prevention of long-term chronicimmunological injury leading to graft impairment.Target audience: Cardiologist, Pneumologists, Cardio-thoracic surgeons, Anestesiologists,Transplant coordinators.
SPECIALTY UPDATE SYMPOSIASunday, September 13, 201509.00 – 12.50 Specialty Update Symposium:VCA: Where are the limits, what is the future?Limitations and results of face transplantationLimitations and results of upper limb transplantationLaryngeal and Tracheal transplantationnd2 Part: Joint Session Basic Science & Vascularized Composite AllotransplantationChronic rejection in VCA: from myth to realityContributions of tissue engineering in VCAWhat have we learned from animal models in VCA?VCA in pills: VCA has opened a new era in the field of transplantation, reconstructive andrestorative surgery. This committee brings together 10 representatives of major Europeanteams at the forefront in this field.Goals: Our goal is to raise the scientific and clinical development of Vascularized CompositeAllotransplantation (VCA) in Europe and to serve as a platform for scientists and clinicians forinformation and exchange.Objectives: Understand the risks and limits of face and upper limb transplantation Discuss and implement new data to characterize chronic rejection Discuss the contribution of animal models in VCA Discuss alternatives strategies for patients' managementTarget audience: Surgeons, physicians, researchers, transplant coordinators.09.00 – 12.50 Specialty Update SymposiumArtificial organs/regenerative medicineRescuing organs (recovering and revitalizing discarded organs)Xenotransplantation (of islets)2nd Part: Joint Session Basic Science & Vascularized Composite AllotransplantationChronic rejection in VCA: from myth to realityContributions of tissue engineering in VCAWhat have we learned from animal models in VCA?BSC in pills: The Basic Science Committee promotes Basic science in transplantation in Europe.Goals: Translation of innovation into clinical activity; Communication between basic scientistsand clinicians; Collaboration between laboratories in Europe.17th Congress of the European Society for Organ Transplantation
SPECIALTY UPDATE SYMPOSIASunday, S
For a major European capital, Brussels is surprisingly eco-friendly too, peppered with parks and green spaces. A walk through Brussels takes you through a potted architectural history, from ancient medieval buildings to strikingly modern edifices, taking in the Art Nouveau styling of illustrious architect Victor Horta along the way.
May 02, 2018 · D. Program Evaluation ͟The organization has provided a description of the framework for how each program will be evaluated. The framework should include all the elements below: ͟The evaluation methods are cost-effective for the organization ͟Quantitative and qualitative data is being collected (at Basics tier, data collection must have begun)
Silat is a combative art of self-defense and survival rooted from Matay archipelago. It was traced at thé early of Langkasuka Kingdom (2nd century CE) till thé reign of Melaka (Malaysia) Sultanate era (13th century). Silat has now evolved to become part of social culture and tradition with thé appearance of a fine physical and spiritual .
On an exceptional basis, Member States may request UNESCO to provide thé candidates with access to thé platform so they can complète thé form by themselves. Thèse requests must be addressed to esd rize unesco. or by 15 A ril 2021 UNESCO will provide thé nomineewith accessto thé platform via their émail address.
̶The leading indicator of employee engagement is based on the quality of the relationship between employee and supervisor Empower your managers! ̶Help them understand the impact on the organization ̶Share important changes, plan options, tasks, and deadlines ̶Provide key messages and talking points ̶Prepare them to answer employee questions
Dr. Sunita Bharatwal** Dr. Pawan Garga*** Abstract Customer satisfaction is derived from thè functionalities and values, a product or Service can provide. The current study aims to segregate thè dimensions of ordine Service quality and gather insights on its impact on web shopping. The trends of purchases have
Chính Văn.- Còn đức Thế tôn thì tuệ giác cực kỳ trong sạch 8: hiện hành bất nhị 9, đạt đến vô tướng 10, đứng vào chỗ đứng của các đức Thế tôn 11, thể hiện tính bình đẳng của các Ngài, đến chỗ không còn chướng ngại 12, giáo pháp không thể khuynh đảo, tâm thức không bị cản trở, cái được
Le genou de Lucy. Odile Jacob. 1999. Coppens Y. Pré-textes. L’homme préhistorique en morceaux. Eds Odile Jacob. 2011. Costentin J., Delaveau P. Café, thé, chocolat, les bons effets sur le cerveau et pour le corps. Editions Odile Jacob. 2010. Crawford M., Marsh D. The driving force : food in human evolution and the future.
Le genou de Lucy. Odile Jacob. 1999. Coppens Y. Pré-textes. L’homme préhistorique en morceaux. Eds Odile Jacob. 2011. Costentin J., Delaveau P. Café, thé, chocolat, les bons effets sur le cerveau et pour le corps. Editions Odile Jacob. 2010. 3 Crawford M., Marsh D. The driving force : food in human evolution and the future.
